Windows 10/8.1 are good operating systems, but not everyone likes the overall design of the Start Menu. Now, there are several options to change the Start Menu to your liking, but today we’re going to ...

Labrys Biologics Secures $31 Million Series A Financing from Venture Capital Firms; Acquires Phase 2 Ready Antibody for Chronic Migraine from Pfizer SAN FRANCISCO, Jan. 3, 2013 /PRNewswire/ -- Labrys ...

JERUSALEM – Teva Pharmaceutical and Labrys Biologics, a privately-held development stage biotechnology company focused on treatments for chronic migraine and episodic migraine, on Tuesday announced ...

Persona 4: Arena’s Labrys is getting her own Figma figuring, as previously reported. This week, Max Factory showed off a few images of her with all of her accessories included on their Figma blog.

in Persona 4 Arena Ultimax’s previous trailer, and now, it’s Labrys’ turn to shine, as she demonstrates her axe-wielding prowess in the upcoming fighter. The trailer starts out with Labrys quoting ...

When Helsing raised a $223 million Series B round, the tech world saw it as continued confirmation that defense was unquestionably back on the investing agenda. Further confirmation comes today, in ...

SAN FRANCISCO, March 18, 2013 /PRNewswire/ -- Labrys Biologics Inc., a company focused on treatments for chronic migraine, today announced key executive appointments to lead the development of RN-307, ...

The note includes an original issue discount of $23,550 and was purchased by Labrys for $157,000. A one-time interest charge of 12% was applied to the principal amount at issuance, totaling $21,666.

SAN FRANCISCO, Jan. 3, 2013 /PRNewswire/ -- Labrys Biologics Inc., a company focused on treatments for chronic migraine, today announced the completion of a $31 Million Series A financing from four ...